- Optimizing the Dosing Regimens of Tigecycline against VancomycinResistant Enterococci in the Treatment of Intra-abdominal and Skin and Soft Tissue Infections
-
Santimaleeworagun W, Hemapanpairoa J, Changpradub D, Thunyaharn S
- KMID: 2507528
- Infect Chemother.
- 2020 Sep;52(3):345-351.
- doi: 10.3947/ic.2020.52.3.345
Tigecycline was previously considered to have activity against vancomycin-resistant Enterococcus (VRE) isolates, but the optimal dose was not clarified. Thus, this study assessed the in vitro activity of tigecycline against... -
- CITED
-
- Close
- SHARE
-
- Close
- Optimization of Linezolid Dosing Regimens for Treatment of VancomycinResistant Enterococci Infection
-
Santimaleeworagun W, Changpradub D, Hemapanpairoa J, Thunyaharn S
- KMID: 2521227
- Infect Chemother.
- 2021 Sep;53(3):503-511.
- doi: 10.3947/ic.2021.0034
Background: Linezolid, an oxazolidinone antibiotic, is recommended for vancomycinresistant enterococci (VRE). However, 100% free-drug concentration above the minimum inhibitory concentration (fT>MIC) and an area under the curve of free drug... -
- CITED
-
- Close
- SHARE
-
- Close
- Vancomycin Area under the Curve and Pharmacokinetic Parameters during the First 24 Hours of Treatment in Critically Ill Patients using Bayesian Forecasting
-
Pongchaidecha M, Changpradub D, Bannalung K, Seejuntra K, Thongmee S, Unnual A, Santimaleeworagun W
- KMID: 2509888
- Infect Chemother.
- 2020 Dec;52(4):573-582.
- doi: 10.3947/ic.2020.52.4.573
Background: Currently, the achievement of the target area under the curve (AUC)/ minimum inhibitory concentration ratio during the first 24 - 48 h of treatment is associated with reduced 30-day... -
- CITED
-
- Close
- SHARE
-
- Close
- Colistin plus Sulbactam or Fosfomycin against Carbapenem-Resistant Acinetobacter baumannii: Improved Efficacy or Decreased Risk of Nephrotoxicity?
-
Saelim W, Changpradub D, Thunyaharn S, Juntanawiwat P, Nulsopapon P, Santimaleeworagun W
- KMID: 2514840
- Infect Chemother.
- 2021 Mar;53(1):128-140.
- doi: 10.3947/ic.2021.0007
Background: Acinetobacter baumannii has been recognized as a cause of nosocomial infection. To date, polymyxins, the last-resort therapeutic agents for carbapenem-resistant A. baumannii (CRAB). Thus, the small number of... -
- CITED
-
- Close
- SHARE
-
- Close
- Fosfomycin Dosing Regimens based on Monte Carlo Simulation for Treated Carbapenem-Resistant Enterobacteriaceae Infection
-
Kanchanasurakit S, Santimaleeworagun W, McPherson, III CE, Piriyachananusorn N, Boonsong B, Katwilat P, Saokaew S
- KMID: 2509883
- Infect Chemother.
- 2020 Dec;52(4):516-529.
- doi: 10.3947/ic.2020.52.4.516
Background: Infections by Carbapenem-Resistant Enterobacteriaceae (CRE) remain a leading cause of death in critically ill patients. Fosfomycin has been regarded as an alternative therapy for treatment of infections caused by... -
- CITED
-
- Close
- SHARE
-
- Close
